Patients who exhibit symptoms of an allergic response to injectable penicillin may actually be experiencing a cardiac reaction that can be avoided with an oral treatment.
The drug, commonly used to treat blood clots, could give physicians another tool in the battle against COVID-19—but much more research is still required.
The new analysis, published in the New England Journal of Medicine, represents the latest chapter in one of interventional cardiology’s largest ongoing debates.